The challenge of type 1 diabetes mellitus.

Larissa Eiselein, Henry J. Schwartz, John C Rutledge

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.

Original languageEnglish (US)
Pages (from-to)231-236
Number of pages6
JournalILAR journal / National Research Council, Institute of Laboratory Animal Resources
Volume45
Issue number3
StatePublished - 2004

Fingerprint

insulin-dependent diabetes mellitus
Medical problems
Type 1 Diabetes Mellitus
insulin
Insulin
insulin secretion
hyperglycemia
diabetes mellitus
immunology
lipid metabolism
blood glucose
diabetes
researchers
Poisons
Immunology
Allergy and Immunology
Lipid Metabolism
Hyperglycemia
Blood Glucose
blood

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The challenge of type 1 diabetes mellitus. / Eiselein, Larissa; Schwartz, Henry J.; Rutledge, John C.

In: ILAR journal / National Research Council, Institute of Laboratory Animal Resources, Vol. 45, No. 3, 2004, p. 231-236.

Research output: Contribution to journalArticle

@article{a9295e53fae640b8b16a4b833b9a408f,
title = "The challenge of type 1 diabetes mellitus.",
abstract = "Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.",
author = "Larissa Eiselein and Schwartz, {Henry J.} and Rutledge, {John C}",
year = "2004",
language = "English (US)",
volume = "45",
pages = "231--236",
journal = "ILAR Journal",
issn = "1084-2020",
publisher = "Institute for Laboratory Animal Research",
number = "3",

}

TY - JOUR

T1 - The challenge of type 1 diabetes mellitus.

AU - Eiselein, Larissa

AU - Schwartz, Henry J.

AU - Rutledge, John C

PY - 2004

Y1 - 2004

N2 - Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.

AB - Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.

UR - http://www.scopus.com/inward/record.url?scp=21644456271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644456271&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 231

EP - 236

JO - ILAR Journal

JF - ILAR Journal

SN - 1084-2020

IS - 3

ER -